Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The Monoclonal Antibody therapy refers to a form of immunotherapy that uses monoclonal antibodies (mAb) to bind mono specifically to certain cells or proteins. Monoclonal antibodies are being used to treat severe and chronic diseases such as rheumatoid arthritis, Crohn's disease, psoriasis, osteoporosis, systemic lupus erythematosus and certain types of cancer.
Increasing focus on biomedical, stem cell and cancer research is a key factor contributing to the dominant market share in North America. The global Monoclonal Antibody Therapeutics market size is expected to gain growth in the forecast period of 2020 to 2026, with a CAGR of 6.9% and will expected to reach USD 146521 million by 2026.
The increasing use of monoclonal antibody therapy in the treatment of cancer and autoimmune diseases is a factor that promotes the market development of Monoclonal Antibody Therapeutics. Besides, increased funding from government agencies for proteomics and genomics research is another factor expected to contribute to market growth during the forecast period. However, factors such as high costs and stringent government regulations will limit market growth over the forecast period.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Monoclonal Antibody Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Monoclonal Antibody Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Monoclonal Antibody Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Roche
Merck
Sanofi
GlaxoSmithKline
AbbVie
Bayer
Pfizer
Novartis
By Type:
Humanized Antibody
Human Mouse Chimeric Antibody
By End-User:
Hospitals
Clinics
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Monoclonal Antibody Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 China Monoclonal Antibody Therapeutics Market Size and Growth Rate of Humanized Antibody from 2016 to 2027
-
1.3.2 China Monoclonal Antibody Therapeutics Market Size and Growth Rate of Human Mouse Chimeric Antibody from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Monoclonal Antibody Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Monoclonal Antibody Therapeutics Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 China Monoclonal Antibody Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Monoclonal Antibody Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Monoclonal Antibody Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Humanized Antibody
-
3.4.2 Market Size and Growth Rate of Human Mouse Chimeric Antibody
4 Segmentation of Monoclonal Antibody Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Monoclonal Antibody Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Monoclonal Antibody Therapeutics in Hospitals
-
4.4.2 Market Size and Growth Rate of Monoclonal Antibody Therapeutics in Clinics
-
4.4.3 Market Size and Growth Rate of Monoclonal Antibody Therapeutics in Others
5 Market Analysis by Regions
-
5.1 China Monoclonal Antibody Therapeutics Production Analysis by Regions
-
5.2 China Monoclonal Antibody Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Monoclonal Antibody Therapeutics Landscape Analysis
-
6.1 North China Monoclonal Antibody Therapeutics Landscape Analysis by Major Types
-
6.2 North China Monoclonal Antibody Therapeutics Landscape Analysis by Major End-Users
7 Central China Monoclonal Antibody Therapeutics Landscape Analysis
-
7.1 Central China Monoclonal Antibody Therapeutics Landscape Analysis by Major Types
-
7.2 Central China Monoclonal Antibody Therapeutics Landscape Analysis by Major End-Users
8 South China Monoclonal Antibody Therapeutics Landscape Analysis
-
8.1 South China Monoclonal Antibody Therapeutics Landscape Analysis by Major Types
-
8.2 South China Monoclonal Antibody Therapeutics Landscape Analysis by Major End-Users
9 East China Monoclonal Antibody Therapeutics Landscape Analysis
-
9.1 East China Monoclonal Antibody Therapeutics Landscape Analysis by Major Types
-
9.2 East China Monoclonal Antibody Therapeutics Landscape Analysis by Major End-Users
10 Northeast China Monoclonal Antibody Therapeutics Landscape Analysis
-
10.1 Northeast China Monoclonal Antibody Therapeutics Landscape Analysis by Major Types
-
10.2 Northeast China Monoclonal Antibody Therapeutics Landscape Analysis by Major End-Users
11 Southwest China Monoclonal Antibody Therapeutics Landscape Analysis
-
11.1 Southwest China Monoclonal Antibody Therapeutics Landscape Analysis by Major Types
-
11.2 Southwest China Monoclonal Antibody Therapeutics Landscape Analysis by Major End-Users
12 Northwest China Monoclonal Antibody Therapeutics Landscape Analysis
-
12.1 Northwest China Monoclonal Antibody Therapeutics Landscape Analysis by Major Types
-
12.2 Northwest China Monoclonal Antibody Therapeutics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Roche
-
13.1.1 Roche Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Merck
-
13.2.1 Merck Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Sanofi
-
13.3.1 Sanofi Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 GlaxoSmithKline
-
13.4.1 GlaxoSmithKline Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 AbbVie
-
13.5.1 AbbVie Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Bayer
-
13.6.1 Bayer Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Pfizer
-
13.7.1 Pfizer Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Novartis
-
13.8.1 Novartis Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Monoclonal Antibody Therapeutics Market Size and Growth Rate of Humanized Antibody from 2016 to 2027
-
Figure China Monoclonal Antibody Therapeutics Market Size and Growth Rate of Human Mouse Chimeric Antibody from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Monoclonal Antibody Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Monoclonal Antibody Therapeutics Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure China Monoclonal Antibody Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Monoclonal Antibody Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Monoclonal Antibody Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Monoclonal Antibody Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Monoclonal Antibody Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Humanized Antibody
-
Figure Market Size and Growth Rate of Human Mouse Chimeric Antibody
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Monoclonal Antibody Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Monoclonal Antibody Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Others
-
Table China Monoclonal Antibody Therapeutics Production by Regions
-
Table China Monoclonal Antibody Therapeutics Production Share by Regions
-
Figure China Monoclonal Antibody Therapeutics Production Share by Regions in 2016
-
Figure China Monoclonal Antibody Therapeutics Production Share by Regions in 2021
-
Figure China Monoclonal Antibody Therapeutics Production Share by Regions in 2027
-
Table China Monoclonal Antibody Therapeutics Consumption by Regions
-
Table China Monoclonal Antibody Therapeutics Consumption Share by Regions
-
Figure China Monoclonal Antibody Therapeutics Consumption Share by Regions in 2016
-
Figure China Monoclonal Antibody Therapeutics Consumption Share by Regions in 2021
-
Figure China Monoclonal Antibody Therapeutics Consumption Share by Regions in 2027
-
Table North China Monoclonal Antibody Therapeutics Consumption by Types from 2016 to 2027
-
Table North China Monoclonal Antibody Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure North China Monoclonal Antibody Therapeutics Consumption Share by Types in 2016
-
Figure North China Monoclonal Antibody Therapeutics Consumption Share by Types in 2021
-
Figure North China Monoclonal Antibody Therapeutics Consumption Share by Types in 2027
-
Table North China Monoclonal Antibody Therapeutics Consumption by End-Users from 2016 to 2027
-
Table North China Monoclonal Antibody Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2016
-
Figure North China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2021
-
Figure North China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2027
-
Table Central China Monoclonal Antibody Therapeutics Consumption by Types from 2016 to 2027
-
Table Central China Monoclonal Antibody Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Central China Monoclonal Antibody Therapeutics Consumption Share by Types in 2016
-
Figure Central China Monoclonal Antibody Therapeutics Consumption Share by Types in 2021
-
Figure Central China Monoclonal Antibody Therapeutics Consumption Share by Types in 2027
-
Table Central China Monoclonal Antibody Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Central China Monoclonal Antibody Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2016
-
Figure Central China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2021
-
Figure Central China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2027
-
Table South China Monoclonal Antibody Therapeutics Consumption by Types from 2016 to 2027
-
Table South China Monoclonal Antibody Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South China Monoclonal Antibody Therapeutics Consumption Share by Types in 2016
-
Figure South China Monoclonal Antibody Therapeutics Consumption Share by Types in 2021
-
Figure South China Monoclonal Antibody Therapeutics Consumption Share by Types in 2027
-
Table South China Monoclonal Antibody Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South China Monoclonal Antibody Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2016
-
Figure South China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2021
-
Figure South China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2027
-
Table East China Monoclonal Antibody Therapeutics Consumption by Types from 2016 to 2027
-
Table East China Monoclonal Antibody Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure East China Monoclonal Antibody Therapeutics Consumption Share by Types in 2016
-
Figure East China Monoclonal Antibody Therapeutics Consumption Share by Types in 2021
-
Figure East China Monoclonal Antibody Therapeutics Consumption Share by Types in 2027
-
Table East China Monoclonal Antibody Therapeutics Consumption by End-Users from 2016 to 2027
-
Table East China Monoclonal Antibody Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2016
-
Figure East China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2021
-
Figure East China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast China Monoclonal Antibody Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast China Monoclonal Antibody Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Monoclonal Antibody Therapeutics Consumption Share by Types in 2016
-
Figure Northeast China Monoclonal Antibody Therapeutics Consumption Share by Types in 2021
-
Figure Northeast China Monoclonal Antibody Therapeutics Consumption Share by Types in 2027
-
Table Northeast China Monoclonal Antibody Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Monoclonal Antibody Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2027
-
Table Southwest China Monoclonal Antibody Therapeutics Consumption by Types from 2016 to 2027
-
Table Southwest China Monoclonal Antibody Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Monoclonal Antibody Therapeutics Consumption Share by Types in 2016
-
Figure Southwest China Monoclonal Antibody Therapeutics Consumption Share by Types in 2021
-
Figure Southwest China Monoclonal Antibody Therapeutics Consumption Share by Types in 2027
-
Table Southwest China Monoclonal Antibody Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Monoclonal Antibody Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2016
-
Figure Southwest China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2021
-
Figure Southwest China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2027
-
Table Northwest China Monoclonal Antibody Therapeutics Consumption by Types from 2016 to 2027
-
Table Northwest China Monoclonal Antibody Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Monoclonal Antibody Therapeutics Consumption Share by Types in 2016
-
Figure Northwest China Monoclonal Antibody Therapeutics Consumption Share by Types in 2021
-
Figure Northwest China Monoclonal Antibody Therapeutics Consumption Share by Types in 2027
-
Table Northwest China Monoclonal Antibody Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Monoclonal Antibody Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2016
-
Figure Northwest China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2021
-
Figure Northwest China Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
